Early clinical response as a predictor of subsequent response to tofacitinib treatment: Results from two phase 3 studies of subjects with moderate to severe plaque psoriasis
2016 ◽
Vol 74
(5)
◽
pp. AB244
Keyword(s):
Phase 3
◽